{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:50:22Z","timestamp":1791989422031,"version":"4.4.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1423-0127-21-14","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T20:01:43Z","timestamp":1392235303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Recent developments in antiviral agents against enterovirus 71 infection"],"prefix":"10.1186","volume":"21","author":[{"given":"Chee Wah","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Kam Fatt","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ching","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoke Fun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,12]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0168-1702(95)00087-9","volume":"39","author":"BA Brown","year":"1995","unstructured":"Brown BA, Pallansch MA: Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995, 39: 195-205. 10.1016\/0168-1702(95)00087-9.","journal-title":"Virus Res"},{"key":"554_CR2","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1126\/science.1218713","volume":"336","author":"P Plevka","year":"2012","unstructured":"Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG: Crystal structure of human enterovirus 71. Science. 2012, 336: 1274-10.1126\/science.1218713.","journal-title":"Science"},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF01317504","volume":"60","author":"M Chumakov","year":"1979","unstructured":"Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, Vasilenko S, Brodvarova I, Nikolova M, Gyurova S: Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979, 60: 329-340. 10.1007\/BF01317504.","journal-title":"Arch Virol"},{"key":"554_CR4","first-page":"284","volume":"23","author":"LM Shindarov","year":"1979","unstructured":"Shindarov LM, Chumakov MP, Voroshilova MK, Bojinov S, Vasilenko SM, Iordanov I, Kirov ID, Kamenov E, Leshchinskaya EV, Mitov G: Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol. 1979, 23: 284-295.","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"key":"554_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF01314873","volume":"71","author":"G Nagy","year":"1982","unstructured":"Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I: Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol. 1982, 71: 217-227. 10.1007\/BF01314873.","journal-title":"Arch Virol"},{"key":"554_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/00365540701799359","volume":"40","author":"KY Huang","year":"2008","unstructured":"Huang KY, Zhang X, Chung PH, Tsao KC, Lin TY, Su LH, Chiu CH: Enterovirus 71 in Taiwan, 2004-2006: epidemiological and virological features. Scand J Infect Dis. 2008, 40: 571-574. 10.1080\/00365540701799359.","journal-title":"Scand J Infect Dis"},{"key":"554_CR7","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1128\/JVI.73.12.9969-9975.1999","volume":"73","author":"BA Brown","year":"1999","unstructured":"Brown BA, Oberste MS, Alexander JP, Kennett ML, Pallansch MA: Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999, 73: 9969-9975.","journal-title":"J Virol"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3201\/eid1301.020112","volume":"9","author":"KP Chan","year":"2003","unstructured":"Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE: Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003, 9: 78-85. 10.3201\/eid1301.020112.","journal-title":"Emerg Infect Dis"},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-1702(99)00019-2","volume":"61","author":"S AbuBakar","year":"1999","unstructured":"AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, Lam SK: Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 1999, 61: 1-9. 10.1016\/S0168-1702(99)00019-2.","journal-title":"Virus Res"},{"key":"554_CR10","doi-asserted-by":"publisher","first-page":"e25662","DOI":"10.1371\/journal.pone.0025662","volume":"6","author":"X Tan","year":"2011","unstructured":"Tan X, Huang X, Zhu S, Chen H, Yu Q, Wang H, Huo X, Zhou J, Wu Y, Yan D: The persistent circulation of enterovirus 71 in People\u2019s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One. 2011, 6: e25662-10.1371\/journal.pone.0025662.","journal-title":"PLoS One"},{"key":"554_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jcv.2009.02.002","volume":"44","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L: An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 2009, 44: 262-267. 10.1016\/j.jcv.2009.02.002.","journal-title":"J Clin Virol"},{"key":"554_CR12","doi-asserted-by":"publisher","first-page":"e27895","DOI":"10.1371\/journal.pone.0027895","volume":"6","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Wang J, Guo W, Wang H, Zhu S, Wang D, Bai R, Li X, Yan D, Zhu Z: Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China. PLoS One. 2011, 6: e27895-10.1371\/journal.pone.0027895.","journal-title":"PLoS One"},{"key":"554_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1743-422X-7-94","volume":"7","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A: An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2010, 7: 94-10.1186\/1743-422X-7-94.","journal-title":"Virol J"},{"key":"554_CR14","first-page":"1004","volume":"28","author":"RN Zhu","year":"2007","unstructured":"Zhu RN, Qian Y, Deng J, Xing JF, Zhao LQ, Wang F, Liao B, Ren XX, Li Y, Zhang Q, Li J: Study on the association of hand, foot and mouth disease and enterovirus 71\/CA16 among children in Beijing, 2007. Zhonghua Liu Xing Bing Xue Za Zhi. 2007, 28: 1004-1008.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"554_CR15","doi-asserted-by":"publisher","first-page":"e69895","DOI":"10.1371\/journal.pone.0069895","volume":"8","author":"PK le Thoa","year":"2013","unstructured":"le Thoa PK, Chiang PS, Khanh TH, Luo ST, Dan TN, Wang YF, Thuong TC, Chung WY, Hung NT, Wang JR: Genetic and antigenic characterization of enterovirus 71 in Ho Chi Minh city, Vietnam, 2011. PLoS One. 2013, 8: e69895-10.1371\/journal.pone.0069895.","journal-title":"PLoS One"},{"key":"554_CR16","first-page":"316","volume":"25","author":"T Biswas","year":"2012","unstructured":"Biswas T: Enterovirus 71 causes hand, foot and mouth disease outbreak in Cambodia. Natl Med J India. 2012, 25: 316-","journal-title":"Natl Med J India"},{"key":"554_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","volume":"9","author":"MH Ooi","year":"2010","unstructured":"Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T: Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010, 9: 1097-1105. 10.1016\/S1474-4422(10)70209-X.","journal-title":"Lancet Neurol"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","volume":"10","author":"T Solomon","year":"2010","unstructured":"Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH: Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010, 10: 778-790. 10.1016\/S1473-3099(10)70194-8.","journal-title":"Lancet Infect Dis"},{"key":"554_CR19","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/S0140-6736(99)04434-7","volume":"354","author":"LY Chang","year":"1999","unstructured":"Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY: Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999, 354: 1682-1686. 10.1016\/S0140-6736(99)04434-7.","journal-title":"Lancet"},{"key":"554_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMoa065954","volume":"356","author":"LY Chang","year":"2007","unstructured":"Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY: Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007, 356: 1226-1234. 10.1056\/NEJMoa065954.","journal-title":"N Engl J Med"},{"key":"554_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.antiviral.2012.12.005","volume":"97","author":"LQ Shang","year":"2013","unstructured":"Shang LQ, Xu MY, Yin Z: Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res. 2013, 97: 183-194. 10.1016\/j.antiviral.2012.12.005.","journal-title":"Antiviral Res"},{"key":"554_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1743-422X-10-28","volume":"10","author":"RL Kuo","year":"2013","unstructured":"Kuo RL, Shih SR: Strategies to develop antivirals against enterovirus 71. Virol J. 2013, 10: 28-10.1186\/1743-422X-10-28.","journal-title":"Virol J"},{"key":"554_CR23","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.4161\/hv.21739","volume":"8","author":"P Chong","year":"2012","unstructured":"Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, Wu SC, Liu SJ, Chow YH, Su IJ, Klein M: Production of EV71 vaccine candidates. Hum Vaccin Immunother. 2012, 8: 1775-1783. 10.4161\/hv.21739.","journal-title":"Hum Vaccin Immunother"},{"key":"554_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jvi.68.1.1-5.1994","volume":"68","author":"AM Haywood","year":"1994","unstructured":"Haywood AM: Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol. 1994, 68: 1-5.","journal-title":"J Virol"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1128\/JVI.02226-12","volume":"87","author":"CW Tan","year":"2013","unstructured":"Tan CW, Poh CL, Sam IC, Chan YF: Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol. 2013, 87: 611-620. 10.1128\/JVI.02226-12.","journal-title":"J Virol"},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1743-422X-6-141","volume":"6","author":"B Yang","year":"2009","unstructured":"Yang B, Chuang H, Yang KD: Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009, 6: 141-10.1186\/1743-422X-6-141.","journal-title":"Virol J"},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2180-12-162","volume":"12","author":"PY Su","year":"2012","unstructured":"Su PY, Liu YT, Chang HY, Huang SW, Wang YF, Yu CK, Wang JR, Chang CF: Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol. 2012, 12: 162-10.1186\/1471-2180-12-162.","journal-title":"BMC Microbiol"},{"key":"554_CR28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nm.1992","volume":"15","author":"S Yamayoshi","year":"2009","unstructured":"Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S: Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009, 15: 798-801. 10.1038\/nm.1992.","journal-title":"Nat Med"},{"key":"554_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nm.1961","volume":"15","author":"Y Nishimura","year":"2009","unstructured":"Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H: Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009, 15: 794-797. 10.1038\/nm.1961.","journal-title":"Nat Med"},{"key":"554_CR30","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1128\/JVI.02070-12","volume":"87","author":"S Yamayoshi","year":"2013","unstructured":"Yamayoshi S, Ohka S, Fujii K, Koike S: Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013, 87: 3335-3347. 10.1128\/JVI.02070-12.","journal-title":"J Virol"},{"key":"554_CR31","doi-asserted-by":"publisher","first-page":"6406","DOI":"10.1074\/jbc.M111.301622","volume":"287","author":"P Chen","year":"2012","unstructured":"Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X: Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem. 2012, 287: 6406-6420. 10.1074\/jbc.M111.301622.","journal-title":"J Biol Chem"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"e57591","DOI":"10.1371\/journal.pone.0057591","volume":"8","author":"YW Lin","year":"2013","unstructured":"Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN, Chitra E, Tsou YL, Chang HW, Sia C: Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One. 2013, 8: e57591-10.1371\/journal.pone.0057591.","journal-title":"PLoS One"},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"14753","DOI":"10.1073\/pnas.1217563110","volume":"110","author":"K Fujii","year":"2013","unstructured":"Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, Shimanuki M, Shitara H, Taya C, Koike S: Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A. 2013, 110: 14753-14758. 10.1073\/pnas.1217563110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"554_CR34","doi-asserted-by":"publisher","first-page":"9064","DOI":"10.1128\/JVI.00573-13","volume":"87","author":"HY Lin","year":"2013","unstructured":"Lin HY, Yang YT, Yu SL, Hsiao KN, Liu CC, Sia C, Chow YH: Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J Virol. 2013, 87: 9064-9076. 10.1128\/JVI.00573-13.","journal-title":"J Virol"},{"key":"554_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00705-011-1198-2","volume":"157","author":"J Liu","year":"2012","unstructured":"Liu J, Dong W, Quan X, Ma C, Qin C, Zhang L: Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch Virol. 2012, 157: 539-543. 10.1007\/s00705-011-1198-2.","journal-title":"Arch Virol"},{"key":"554_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.virusres.2012.06.025","volume":"169","author":"HR Pourianfar","year":"2012","unstructured":"Pourianfar HR, Poh CL, Fecondo J, Grollo L: In vitro evaluation of the antiviral activity of heparan sulphate mimetic compounds against enterovirus 71. Virus Res. 2012, 169: 22-29. 10.1016\/j.virusres.2012.06.025.","journal-title":"Virus Res"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","volume":"89","author":"M Arita","year":"2008","unstructured":"Arita M, Wakita T, Shimizu H: Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J Gen Virol. 2008, 89: 2518-2530. 10.1099\/vir.0.2008\/002915-0.","journal-title":"J Gen Virol"},{"key":"554_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.antiviral.2012.05.009","volume":"95","author":"YH Chiu","year":"2012","unstructured":"Chiu YH, Chan YL, Tsai LW, Li TL, Wu CJ: Prevention of human enterovirus 71 infection by kappa carrageenan. Antiviral Res. 2012, 95: 128-134. 10.1016\/j.antiviral.2012.05.009.","journal-title":"Antiviral Res"},{"key":"554_CR39","doi-asserted-by":"publisher","first-page":"e34589","DOI":"10.1371\/journal.pone.0034589","volume":"7","author":"CW Tan","year":"2012","unstructured":"Tan CW, Chan YF, Sim KM, Tan EL, Poh CL: Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1. PLoS One. 2012, 7: e34589-10.1371\/journal.pone.0034589.","journal-title":"PLoS One"},{"key":"554_CR40","doi-asserted-by":"publisher","first-page":"25406","DOI":"10.1074\/jbc.M110.201103","volume":"286","author":"V Tiwari","year":"2011","unstructured":"Tiwari V, Liu J, Valyi-Nagy T, Shukla D: Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J Biol Chem. 2011, 286: 25406-25415. 10.1074\/jbc.M110.201103.","journal-title":"J Biol Chem"},{"key":"554_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.vaccine.2007.12.013","volume":"26","author":"HL Chen","year":"2008","unstructured":"Chen HL, Wang LC, Chang CH, Yen CC, Cheng WT, Wu SC, Hung CM, Kuo MF, Chen CM: Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71. Vaccine. 2008, 26: 891-898. 10.1016\/j.vaccine.2007.12.013.","journal-title":"Vaccine"},{"key":"554_CR42","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1086\/343809","volume":"186","author":"TY Lin","year":"2002","unstructured":"Lin TY, Chu C, Chiu CH: Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J Infect Dis. 2002, 186: 1161-1164. 10.1086\/343809.","journal-title":"J Infect Dis"},{"key":"554_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2005.03.005","volume":"67","author":"TY Weng","year":"2005","unstructured":"Weng TY, Chen LC, Shyu HW, Chen SH, Wang JR, Yu CK, Lei HY, Yeh TM: Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Res. 2005, 67: 31-37. 10.1016\/j.antiviral.2005.03.005.","journal-title":"Antiviral Res"},{"key":"554_CR44","doi-asserted-by":"publisher","first-page":"e1003240","DOI":"10.1371\/journal.ppat.1003240","volume":"9","author":"KL Shingler","year":"2013","unstructured":"Shingler KL, Yoder JL, Carnegie MS, Ashley RE, Makhov AM, Conway JF, Hafenstein S: The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. 2013, 9: e1003240-10.1371\/journal.ppat.1003240.","journal-title":"PLoS Pathog"},{"key":"554_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1128\/AAC.30.1.110","volume":"30","author":"MP Fox","year":"1986","unstructured":"Fox MP, Otto MJ, McKinlay MA: Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob Agents Chemother. 1986, 30: 110-116. 10.1128\/AAC.30.1.110.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR46","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/infdis\/154.4.676","volume":"154","author":"MA McKinlay","year":"1986","unstructured":"McKinlay MA, Frank JA, Benziger DP, Steinberg BA: Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice. J Infect Dis. 1986, 154: 676-681. 10.1093\/infdis\/154.4.676.","journal-title":"J Infect Dis"},{"key":"554_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1128\/AAC.36.2.425","volume":"36","author":"DM See","year":"1992","unstructured":"See DM, Tilles JG: Treatment of coxsackievirus A9 myocarditis in mice with WIN 54954. Antimicrob Agents Chemother. 1992, 36: 425-428. 10.1128\/AAC.36.2.425.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR48","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.1222379110","volume":"110","author":"P Plevka","year":"2013","unstructured":"Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG: Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A. 2013, 110: 5463-5467. 10.1073\/pnas.1222379110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"554_CR49","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1021\/jm010536a","volume":"45","author":"KS Shia","year":"2002","unstructured":"Shia KS, Li WT, Chang CM, Hsu MC, Chern JH, Leong MK, Tseng SN, Lee CC, Lee YC, Chen SJ: Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J Med Chem. 2002, 45: 1644-1655. 10.1021\/jm010536a.","journal-title":"J Med Chem"},{"key":"554_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/med.10067","volume":"24","author":"SR Shih","year":"2004","unstructured":"Shih SR, Chen SJ, Hakimelahi GH, Liu HJ, Tseng CT, Shia KS: Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules. Med Res Rev. 2004, 24: 449-474. 10.1002\/med.10067.","journal-title":"Med Res Rev"},{"key":"554_CR51","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1128\/AAC.48.9.3523-3529.2004","volume":"48","author":"SR Shih","year":"2004","unstructured":"Shih SR, Tsai MC, Tseng SN, Won KF, Shia KS, Li WT, Chern JH, Chen GW, Lee CC, Lee YC: Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob Agents Chemother. 2004, 48: 3523-3529. 10.1128\/AAC.48.9.3523-3529.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR52","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11373-007-9228-5","volume":"15","author":"TC Chen","year":"2008","unstructured":"Chen TC, Liu SC, Huang PN, Chang HY, Chern JH, Shih SR: Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. J Biomed Sci. 2008, 15: 291-300. 10.1007\/s11373-007-9228-5.","journal-title":"J Biomed Sci"},{"key":"554_CR53","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.bmcl.2004.02.092","volume":"14","author":"JH Chern","year":"2004","unstructured":"Chern JH, Shia KS, Hsu TA, Tai CL, Lee CC, Lee YC, Chang CS, Tseng SN, Shih SR: Design, synthesis, and structure-activity relationships of pyrazolo [3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors. Bioorg Med Chem Lett. 2004, 14: 2519-2525. 10.1016\/j.bmcl.2004.02.092.","journal-title":"Bioorg Med Chem Lett"},{"key":"554_CR54","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1021\/jm050033v","volume":"48","author":"CS Chang","year":"2005","unstructured":"Chang CS, Lin YT, Shih SR, Lee CC, Lee YC, Tai CL, Tseng SN, Chern JH: Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives. J Med Chem. 2005, 48: 3522-3535. 10.1021\/jm050033v.","journal-title":"J Med Chem"},{"key":"554_CR55","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","volume":"43","author":"DC Pevear","year":"1999","unstructured":"Pevear DC, Tull TM, Seipel ME, Groarke JM: Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 1999, 43: 2109-2115.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR56","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","volume":"157","author":"G Zhang","year":"2012","unstructured":"Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, Wang J, Zhang C, Cao Q, Deng Y: In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch Virol. 2012, 157: 669-679. 10.1007\/s00705-011-1222-6.","journal-title":"Arch Virol"},{"key":"554_CR57","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1128\/AAC.48.5.1766-1772.2004","volume":"48","author":"DL Barnard","year":"2004","unstructured":"Barnard DL, Hubbard VD, Smee DF, Sidwell RW, Watson KG, Tucker SP, Reece PA: In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrob Agents Chemother. 2004, 48: 1766-1772. 10.1128\/AAC.48.5.1766-1772.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR58","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0022-2836(91)90749-V","volume":"217","author":"MS Chapman","year":"1991","unstructured":"Chapman MS, Minor I, Rossmann MG, Diana GD, Andries K: Human rhinovirus 14 complexed with antiviral compound R 61837. J Mol Biol. 1991, 217: 455-463. 10.1016\/0022-2836(91)90749-V.","journal-title":"J Mol Biol"},{"key":"554_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0166-3542(95)00088-4","volume":"27","author":"D Genovese","year":"1995","unstructured":"Genovese D, Conti C, Tomao P, Desideri N, Stein ML, Catone S, Fiore L: Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Res. 1995, 27: 123-136. 10.1016\/0166-3542(95)00088-4.","journal-title":"Antiviral Res"},{"key":"554_CR60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/095632029800900607","volume":"9","author":"C Conti","year":"1998","unstructured":"Conti C, Mastromarino P, Sgro R, Desideri N: Anti-picornavirus activity of synthetic flavon-3-yl esters. Antivir Chem Chemother. 1998, 9: 511-515.","journal-title":"Antivir Chem Chemother"},{"key":"554_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/292369a0","volume":"292","author":"DJ Bauer","year":"1981","unstructured":"Bauer DJ, Selway JW, Batchelor JF, Tisdale M, Caldwell IC, Young DA: 4\u2032,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound. Nature. 1981, 292: 369-370. 10.1038\/292369a0.","journal-title":"Nature"},{"key":"554_CR62","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1099\/0022-1317-64-4-795","volume":"64","author":"M Tisdale","year":"1983","unstructured":"Tisdale M, Selway JW: Inhibition of an early stage of rhinovirus replication by dichloroflavan (BW683C). J Gen Virol. 1983, 64: 795-803. 10.1099\/0022-1317-64-4-795.","journal-title":"J Gen Virol"},{"issue":"Suppl A","key":"554_CR63","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/jac\/14.suppl_A.97","volume":"14","author":"M Tisdale","year":"1984","unstructured":"Tisdale M, Selway JW: Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B. J Antimicrob Chemother. 1984, 14 (Suppl A): 97-105. 10.1093\/jac\/14.suppl_A.97.","journal-title":"J Antimicrob Chemother"},{"key":"554_CR64","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0042-6822(03)00544-0","volume":"315","author":"SR Thompson","year":"2003","unstructured":"Thompson SR, Sarnow P: Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology. 2003, 315: 259-266. 10.1016\/S0042-6822(03)00544-0.","journal-title":"Virology"},{"key":"554_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1423-0127-16-103","volume":"16","author":"JY Lin","year":"2009","unstructured":"Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR: Viral and host proteins involved in picornavirus life cycle. J Biomed Sci. 2009, 16: 103-10.1186\/1423-0127-16-103.","journal-title":"J Biomed Sci"},{"key":"554_CR66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd3625","volume":"11","author":"R Kole","year":"2012","unstructured":"Kole R, Krainer AR, Altman S: RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov. 2012, 11: 125-140.","journal-title":"Nat Rev Drug Discov"},{"key":"554_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1423-0127-19-73","volume":"19","author":"JX Deng","year":"2012","unstructured":"Deng JX, Nie XJ, Lei YF, Ma CF, Xu DL, Li B, Xu ZK, Zhang GC: The highly conserved 5\u2032 untranslated region as an effective target towards the inhibition of enterovirus 71 replication by unmodified and appropriate 2\u2032- modified siRNAs. J Biomed Sci. 2012, 19: 73-10.1186\/1423-0127-19-73.","journal-title":"J Biomed Sci"},{"key":"554_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jviromet.2009.04.002","volume":"159","author":"Z Wu","year":"2009","unstructured":"Wu Z, Yang F, Zhao R, Zhao L, Guo D, Jin Q: Identification of small interfering RNAs which inhibit the replication of several enterovirus 71 strains in China. J Virol Methods. 2009, 159: 233-238. 10.1016\/j.jviromet.2009.04.002.","journal-title":"J Virol Methods"},{"key":"554_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virol.2005.06.047","volume":"341","author":"AC Sim","year":"2005","unstructured":"Sim AC, Luhur A, Tan TM, Chow VT, Poh CL: RNA interference against enterovirus 71 infection. Virology. 2005, 341: 72-79. 10.1016\/j.virol.2005.06.047.","journal-title":"Virology"},{"key":"554_CR70","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/sj.mt.6300287","volume":"15","author":"EL Tan","year":"2007","unstructured":"Tan EL, Tan TM, Tak Kwong Chow V, Poh CL: Inhibition of enterovirus 71 in virus-infected mice by RNA interference. Mol Ther. 2007, 15: 1931-1938. 10.1038\/sj.mt.6300287.","journal-title":"Mol Ther"},{"key":"554_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.antiviral.2007.01.004","volume":"74","author":"EL Tan","year":"2007","unstructured":"Tan EL, Tan TM, Chow VT, Poh CL: Enhanced potency and efficacy of 29-mer shRNAs in inhibition of enterovirus 71. Antiviral Res. 2007, 74: 9-15. 10.1016\/j.antiviral.2007.01.004.","journal-title":"Antiviral Res"},{"key":"554_CR72","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbrc.2004.10.062","volume":"325","author":"WW Lu","year":"2004","unstructured":"Lu WW, Hsu YY, Yang JY, Kung SH: Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem Biophys Res Commun. 2004, 325: 494-499. 10.1016\/j.bbrc.2004.10.062.","journal-title":"Biochem Biophys Res Commun"},{"key":"554_CR73","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1128\/AAC.00011-08","volume":"52","author":"JK Stone","year":"2008","unstructured":"Stone JK, Rijnbrand R, Stein DA, Ma Y, Yang Y, Iversen PL, Andino R: A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus. Antimicrob Agents Chemother. 2008, 52: 1970-1981. 10.1128\/AAC.00011-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR74","doi-asserted-by":"publisher","first-page":"11510","DOI":"10.1128\/JVI.00900-06","volume":"80","author":"J Yuan","year":"2006","unstructured":"Yuan J, Stein DA, Lim T, Qiu D, Coughlin S, Liu Z, Wang Y, Blouch R, Moulton HM, Iversen PL, Yang D: Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site. J Virol. 2006, 80: 11510-11519. 10.1128\/JVI.00900-06.","journal-title":"J Virol"},{"key":"554_CR75","doi-asserted-by":"publisher","first-page":"e52954","DOI":"10.1371\/journal.pone.0052954","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, Du J, Wu Z, Jin Q: Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites. PLoS One. 2013, 8: e52954-10.1371\/journal.pone.0052954.","journal-title":"PLoS One"},{"key":"554_CR76","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.foodchem.2011.03.022","volume":"128","author":"FJ Tsai","year":"2011","unstructured":"Tsai FJ, Lin CW, Lai CC, Lan YC, Lai CH, Hung CH, Hsueh KC, Lin TH, Chang HC, Wan L: Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem. 2011, 128: 312-322. 10.1016\/j.foodchem.2011.03.022.","journal-title":"Food Chem"},{"key":"554_CR77","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2012.12.038","volume":"62","author":"YJ Lin","year":"2013","unstructured":"Lin YJ, Lai CC, Lai CH, Sue SC, Lin CW, Hung CH, Lin TH, Hsu WY, Huang SM, Hung YL: Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide. Eur J Med Chem. 2013, 62: 206-213.","journal-title":"Eur J Med Chem"},{"key":"554_CR78","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1745-7254.2008.00876.x","volume":"29","author":"YJ Chen","year":"2008","unstructured":"Chen YJ, Zeng SJ, Hsu JT, Horng JT, Yang HM, Shih SR, Chu YT, Wu TY: Amantadine as a regulator of internal ribosome entry site. Acta Pharmacol Sin. 2008, 29: 1327-1333. 10.1111\/j.1745-7254.2008.00876.x.","journal-title":"Acta Pharmacol Sin"},{"key":"554_CR79","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4049\/jimmunol.95.6.1090","volume":"95","author":"WL Davies","year":"1965","unstructured":"Davies WL, Grunert RR, Hoffmann CE: Influenza virus growth and antibody response in amantadine-treated mice. J Immunol. 1965, 95: 1090-1094.","journal-title":"J Immunol"},{"key":"554_CR80","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/jb.90.3.623-628.1965","volume":"90","author":"CE Hoffmann","year":"1965","unstructured":"Hoffmann CE, Neumayer EM, Haff RF, Goldsby RA: Mode of action of the antiviral activity of amantadine in tissue culture. J Bacteriol. 1965, 90: 623-628.","journal-title":"J Bacteriol"},{"key":"554_CR81","doi-asserted-by":"publisher","first-page":"e1003231","DOI":"10.1371\/journal.ppat.1003231","volume":"9","author":"B Wang","year":"2013","unstructured":"Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z: Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013, 9: e1003231-10.1371\/journal.ppat.1003231.","journal-title":"PLoS Pathog"},{"key":"554_CR82","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1128\/JVI.01855-12","volume":"87","author":"X Lei","year":"2013","unstructured":"Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J: Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol. 2013, 87: 1690-1698. 10.1128\/JVI.01855-12.","journal-title":"J Virol"},{"key":"554_CR83","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/jac\/dks304","volume":"67","author":"N Falah","year":"2012","unstructured":"Falah N, Montserret R, Lelogeais V, Schuffenecker I, Lina B, Cortay JC, Violot S: Blocking human enterovirus 71 replication by targeting viral 2A protease. J Antimicrob Chemother. 2012, 67: 2865-2869. 10.1093\/jac\/dks304.","journal-title":"J Antimicrob Chemother"},{"key":"554_CR84","first-page":"297","volume":"1","author":"G Witherell","year":"2000","unstructured":"Witherell G: AG-7088 Pfizer. Curr Opin Investig Drugs. 2000, 1: 297-302.","journal-title":"Curr Opin Investig Drugs"},{"key":"554_CR85","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1128\/AAC.49.2.619-626.2005","volume":"49","author":"SL Binford","year":"2005","unstructured":"Binford SL, Maldonado F, Brothers MA, Weady PT, Zalman LS, Meador JW, Matthews DA, Patick AK: Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother. 2005, 49: 619-626. 10.1128\/AAC.49.2.619-626.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR86","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1128\/AAC.00905-07","volume":"51","author":"SL Binford","year":"2007","unstructured":"Binford SL, Weady PT, Maldonado F, Brothers MA, Matthews DA, Patick AK: In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother. 2007, 51: 4366-4373. 10.1128\/AAC.00905-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR87","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.antiviral.2006.03.011","volume":"71","author":"AK Patick","year":"2006","unstructured":"Patick AK: Rhinovirus chemotherapy. Antiviral Res. 2006, 71: 391-396. 10.1016\/j.antiviral.2006.03.011.","journal-title":"Antiviral Res"},{"key":"554_CR88","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1128\/AAC.43.10.2444","volume":"43","author":"AK Patick","year":"1999","unstructured":"Patick AK, Binford SL, Brothers MA, Jackson RL, Ford CE, Diem MD, Maldonado F, Dragovich PS, Zhou R, Prins TJ: In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother. 1999, 43: 2444-2450.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR89","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1128\/AAC.49.6.2267-2275.2005","volume":"49","author":"AK Patick","year":"2005","unstructured":"Patick AK, Brothers MA, Maldonado F, Binford S, Maldonado O, Fuhrman S, Petersen A, Smith GJ, Zalman LS, Burns-Naas LA, Tran JQ: In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother. 2005, 49: 2267-2275. 10.1128\/AAC.49.6.2267-2275.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR90","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3748\/wjg.v16.i2.201","volume":"16","author":"XN Zhang","year":"2010","unstructured":"Zhang XN, Song ZG, Jiang T, Shi BS, Hu YW, Yuan ZH: Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. World J Gastroenterol. 2010, 16: 201-209. 10.3748\/wjg.v16.i2.201.","journal-title":"World J Gastroenterol"},{"key":"554_CR91","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/infdis\/jir174","volume":"203","author":"HC Hung","year":"2011","unstructured":"Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JT: Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis. 2011, 203: 1784-1790. 10.1093\/infdis\/jir174.","journal-title":"J Infect Dis"},{"key":"554_CR92","doi-asserted-by":"publisher","first-page":"10319","DOI":"10.1128\/JVI.00787-11","volume":"85","author":"G Lu","year":"2011","unstructured":"Lu G, Qi J, Chen Z, Xu X, Gao F, Lin D, Qian W, Liu H, Jiang H, Yan J, Gao GF: Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J Virol. 2011, 85: 10319-10331. 10.1128\/JVI.00787-11.","journal-title":"J Virol"},{"key":"554_CR93","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.antiviral.2012.12.029","volume":"97","author":"X Zhang","year":"2013","unstructured":"Zhang X, Song Z, Qin B, Chen L, Hu Y, Yuan Z: Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antiviral Res. 2013, 97: 264-269. 10.1016\/j.antiviral.2012.12.029.","journal-title":"Antiviral Res"},{"key":"554_CR94","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.1128\/JVI.05107-11","volume":"85","author":"J Wang","year":"2011","unstructured":"Wang J, Fan T, Yao X, Wu Z, Guo L, Lei X, Wang M, Jin Q, Cui S: Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J Virol. 2011, 85: 10021-10030. 10.1128\/JVI.05107-11.","journal-title":"J Virol"},{"key":"554_CR95","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1107\/S0907444913002862","volume":"69","author":"C Wu","year":"2013","unstructured":"Wu C, Cai Q, Chen C, Li N, Peng X, Cai Y, Yin K, Chen X, Wang X, Zhang R: Structures of enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir. Acta Crystallogr D Biol Crystallogr. 2013, 69: 866-871. 10.1107\/S0907444913002862.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"554_CR96","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1016\/j.bmc.2008.06.015","volume":"16","author":"CJ Kuo","year":"2008","unstructured":"Kuo CJ, Shie JJ, Fang JM, Yen GR, Hsu JT, Liu HG, Tseng SN, Chang SC, Lee CY, Shih SR, Liang PH: Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem. 2008, 16: 7388-7398. 10.1016\/j.bmc.2008.06.015.","journal-title":"Bioorg Med Chem"},{"key":"554_CR97","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jviromet.2012.03.020","volume":"182","author":"YJ Lin","year":"2012","unstructured":"Lin YJ, Chang YC, Hsiao NW, Hsieh JL, Wang CY, Kung SH, Tsai FJ, Lan YC, Lin CW: Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J Virol Methods. 2012, 182: 93-98. 10.1016\/j.jviromet.2012.03.020.","journal-title":"J Virol Methods"},{"key":"554_CR98","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1128\/JVI.75.20.9808-9818.2001","volume":"75","author":"RC Rust","year":"2001","unstructured":"Rust RC, Landmann L, Gosert R, Tang BL, Hong W, Hauri HP, Egger D, Bienz K: Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. J Virol. 2001, 75: 9808-9818. 10.1128\/JVI.75.20.9808-9818.2001.","journal-title":"J Virol"},{"key":"554_CR99","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1128\/JVI.74.14.6570-6580.2000","volume":"74","author":"D Egger","year":"2000","unstructured":"Egger D, Teterina N, Ehrenfeld E, Bienz K: Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol. 2000, 74: 6570-6580. 10.1128\/JVI.74.14.6570-6580.2000.","journal-title":"J Virol"},{"key":"554_CR100","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1371\/journal.pbio.0030156","volume":"3","author":"WT Jackson","year":"2005","unstructured":"Jackson WT, Giddings TH, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, Kirkegaard K: Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 2005, 3: e156-10.1371\/journal.pbio.0030156.","journal-title":"PLoS Biol"},{"key":"554_CR101","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/jmv.21502","volume":"81","author":"SC Huang","year":"2009","unstructured":"Huang SC, Chang CL, Wang PS, Tsai Y, Liu HS: Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J Med Virol. 2009, 81: 1241-1252. 10.1002\/jmv.21502.","journal-title":"J Med Virol"},{"key":"554_CR102","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1099\/vir.0.012096-0","volume":"90","author":"M Arita","year":"2009","unstructured":"Arita M, Wakita T, Shimizu H: Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime. J Gen Virol. 2009, 90: 1869-1879. 10.1099\/vir.0.012096-0.","journal-title":"J Gen Virol"},{"key":"554_CR103","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2006.11.137","volume":"353","author":"Y Shima","year":"2007","unstructured":"Shima Y, Okamoto T, Aoyama T, Yasura K, Ishibe T, Nishijo K, Shibata KR, Kohno Y, Fukiage K, Otsuka S: In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12. Biochem Biophys Res Commun. 2007, 353: 60-66. 10.1016\/j.bbrc.2006.11.137.","journal-title":"Biochem Biophys Res Commun"},{"key":"554_CR104","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/MCB.00166-09","volume":"29","author":"G Bellot","year":"2009","unstructured":"Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM: Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol. 2009, 29: 2570-2581. 10.1128\/MCB.00166-09.","journal-title":"Mol Cell Biol"},{"key":"554_CR105","doi-asserted-by":"publisher","first-page":"e77133","DOI":"10.1371\/journal.pone.0077133","volume":"8","author":"YL Tsou","year":"2013","unstructured":"Tsou YL, Lin YW, Chang HW, Lin HY, Shao HY, Yu SL, Liu CC, Chitra E, Sia C, Chow YH: Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy. PLoS One. 2013, 8: e77133-10.1371\/journal.pone.0077133.","journal-title":"PLoS One"},{"key":"554_CR106","doi-asserted-by":"publisher","first-page":"e1002331","DOI":"10.1371\/journal.ppat.1002331","volume":"7","author":"S Pfefferle","year":"2011","unstructured":"Pfefferle S, Schopf J, Kogl M, Friedel CC, Muller MA, Carbajo-Lozoya J, Stellberger T, von Dall\u2019Armi E, Herzog P, Kallies S: The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 2011, 7: e1002331-10.1371\/journal.ppat.1002331.","journal-title":"PLoS Pathog"},{"key":"554_CR107","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jhep.2007.03.028","volume":"47","author":"P Marcellin","year":"2007","unstructured":"Marcellin P, Horsmans Y, Nevens F, Grange JD, Bronowicki JP, Vetter D, Purdy S, Garg V, Bengtsson L, McNair L, Alam J: Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. J Hepatol. 2007, 47: 476-483. 10.1016\/j.jhep.2007.03.028.","journal-title":"J Hepatol"},{"key":"554_CR108","doi-asserted-by":"publisher","first-page":"11315","DOI":"10.1128\/JVI.05421-11","volume":"85","author":"L Martinez-Gil","year":"2011","unstructured":"Martinez-Gil L, Bano-Polo M, Redondo N, Sanchez-Martinez S, Nieva JL, Carrasco L, Mingarro I: Membrane integration of poliovirus 2B viroporin. J Virol. 2011, 85: 11315-11324. 10.1128\/JVI.05421-11.","journal-title":"J Virol"},{"key":"554_CR109","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/cr.2011.112","volume":"21","author":"S Xie","year":"2011","unstructured":"Xie S, Wang K, Yu W, Lu W, Xu K, Wang J, Ye B, Schwarz W, Jin Q, Sun B: DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71. Cell Res. 2011, 21: 1271-1275. 10.1038\/cr.2011.112.","journal-title":"Cell Res"},{"key":"554_CR110","doi-asserted-by":"publisher","first-page":"22012","DOI":"10.1074\/jbc.M109.031807","volume":"284","author":"P Adams","year":"2009","unstructured":"Adams P, Kandiah E, Effantin G, Steven AC, Ehrenfeld E: Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. J Biol Chem. 2009, 284: 22012-22021. 10.1074\/jbc.M109.031807.","journal-title":"J Biol Chem"},{"key":"554_CR111","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1128\/JVI.74.9.4146-4154.2000","volume":"74","author":"H Shimizu","year":"2000","unstructured":"Shimizu H, Agoh M, Agoh Y, Yoshida H, Yoshii K, Yoneyama T, Hagiwara A, Miyamura T: Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. J Virol. 2000, 74: 4146-4154. 10.1128\/JVI.74.9.4146-4154.2000.","journal-title":"J Virol"},{"key":"554_CR112","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1128\/AAC.00934-08","volume":"53","author":"AM De Palma","year":"2009","unstructured":"De Palma AM, Thibaut HJ, van der Linden L, Lanke K, Heggermont W, Ireland S, Andrews R, Arimilli M, Al-Tel TH, De Clercq E: Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother. 2009, 53: 1850-1857. 10.1128\/AAC.00934-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR113","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0042-6822(68)90139-6","volume":"36","author":"LA Caliguiri","year":"1968","unstructured":"Caliguiri LA, Tamm I: Distribution and translation of poliovirus RNA in guanidine-treated cells. Virology. 1968, 36: 223-231. 10.1016\/0042-6822(68)90139-6.","journal-title":"Virology"},{"key":"554_CR114","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/0042-6822(68)90219-5","volume":"35","author":"LA Caliguiri","year":"1968","unstructured":"Caliguiri LA, Tamm I: Action of guanidine on the replication of poliovirus RNA. Virology. 1968, 35: 408-417. 10.1016\/0042-6822(68)90219-5.","journal-title":"Virology"},{"key":"554_CR115","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/193097a0","volume":"193","author":"B Loddo","year":"1962","unstructured":"Loddo B, Ferrari W, Brotzu G, Spanedda A: In vitro inhibition of infectivity of polio viruses by guanidine. Nature. 1962, 193: 97-98. 10.1038\/193097a0.","journal-title":"Nature"},{"key":"554_CR116","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.134.3478.558","volume":"134","author":"WA Rightsel","year":"1961","unstructured":"Rightsel WA, Dice JR, Mc AR, Timm EA, Mc LI, Dixon GJ, Schabel FM: Antiviral effect of guanidine. Science. 1961, 134: 558-559. 10.1126\/science.134.3478.558.","journal-title":"Science"},{"key":"554_CR117","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0166-3542(82)90003-1","volume":"2","author":"EC Herrmann Jr","year":"1982","unstructured":"Herrmann EC, Herrmann JA, Delong DC: Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles. Antiviral Res. 1982, 2: 339-346. 10.1016\/0166-3542(82)90003-1.","journal-title":"Antiviral Res"},{"key":"554_CR118","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/jvi.56.3.921-929.1985","volume":"56","author":"K Saunders","year":"1985","unstructured":"Saunders K, King AM, McCahon D, Newman JW, Slade WR, Forss S: Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants. J Virol. 1985, 56: 921-929.","journal-title":"J Virol"},{"key":"554_CR119","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virusres.2012.07.005","volume":"169","author":"S Sadeghipour","year":"2012","unstructured":"Sadeghipour S, Bek EJ, McMinn PC: Selection and characterisation of guanidine-resistant mutants of human enterovirus 71. Virus Res. 2012, 169: 72-79. 10.1016\/j.virusres.2012.07.005.","journal-title":"Virus Res"},{"key":"554_CR120","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1128\/jvi.64.3.1156-1163.1990","volume":"64","author":"K Bienz","year":"1990","unstructured":"Bienz K, Egger D, Troxler M, Pasamontes L: Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J Virol. 1990, 64: 1156-1163.","journal-title":"J Virol"},{"key":"554_CR121","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1128\/JVI.01819-08","volume":"83","author":"MP Taylor","year":"2009","unstructured":"Taylor MP, Burgon TB, Kirkegaard K, Jackson WT: Role of microtubules in extracellular release of poliovirus. J Virol. 2009, 83: 6599-6609. 10.1128\/JVI.01819-08.","journal-title":"J Virol"},{"key":"554_CR122","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1128\/JVI.79.8.5163-5173.2005","volume":"79","author":"E Wessels","year":"2005","unstructured":"Wessels E, Duijsings D, Notebaart RA, Melchers WJ, van Kuppeveld FJ: A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J Virol. 2005, 79: 5163-5173. 10.1128\/JVI.79.8.5163-5173.2005.","journal-title":"J Virol"},{"key":"554_CR123","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/med.20125","volume":"28","author":"AM De Palma","year":"2008","unstructured":"De Palma AM, Vliegen I, De Clercq E, Neyts J: Selective inhibitors of picornavirus replication. Med Res Rev. 2008, 28: 823-884. 10.1002\/med.20125.","journal-title":"Med Res Rev"},{"key":"554_CR124","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1099\/vir.0.023374-0","volume":"91","author":"M Arita","year":"2010","unstructured":"Arita M, Takebe Y, Wakita T, Shimizu H: A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection. J Gen Virol. 2010, 91: 2734-2744. 10.1099\/vir.0.023374-0.","journal-title":"J Gen Virol"},{"key":"554_CR125","doi-asserted-by":"publisher","first-page":"16202","DOI":"10.1074\/jbc.M610608200","volume":"282","author":"HB Pathak","year":"2007","unstructured":"Pathak HB, Arnold JJ, Wiegand PN, Hargittai MR, Cameron CE: Picornavirus genome replication: assembly and organization of the VPg uridylylation ribonucleoprotein (initiation) complex. J Biol Chem. 2007, 282: 16202-16213. 10.1074\/jbc.M610608200.","journal-title":"J Biol Chem"},{"key":"554_CR126","doi-asserted-by":"publisher","first-page":"10359","DOI":"10.1128\/JVI.74.22.10359-10370.2000","volume":"74","author":"AV Paul","year":"2000","unstructured":"Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E: Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol. 2000, 74: 10359-10370. 10.1128\/JVI.74.22.10359-10370.2000.","journal-title":"J Virol"},{"key":"554_CR127","doi-asserted-by":"publisher","first-page":"13662","DOI":"10.1128\/JVI.01712-12","volume":"86","author":"Y Sun","year":"2012","unstructured":"Sun Y, Wang Y, Shan C, Chen C, Xu P, Song M, Zhou H, Yang C, Xu W, Shi PY: Enterovirus-71 VPg uridylylation uses a two-molecular mechanism of 3Dpol. J Virol. 2012, 86: 13662-13671. 10.1128\/JVI.01712-12.","journal-title":"J Virol"},{"key":"554_CR128","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1128\/AAC.01056-07","volume":"52","author":"JD Graci","year":"2008","unstructured":"Graci JD, Too K, Smidansky ED, Edathil JP, Barr EW, Harki DA, Galarraga JE, Bollinger JM, Peterson BR, Loakes D: Lethal mutagenesis of picornaviruses with N-6-modified purine nucleoside analogues. Antimicrob Agents Chemother. 2008, 52: 971-979. 10.1128\/AAC.01056-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR129","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1086\/527326","volume":"197","author":"ZH Li","year":"2008","unstructured":"Li ZH, Li CM, Ling P, Shen FH, Chen SH, Liu CC, Yu CK: Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis. 2008, 197: 854-857. 10.1086\/527326.","journal-title":"J Infect Dis"},{"key":"554_CR130","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1128\/AAC.00101-09","volume":"53","author":"TC Chen","year":"2009","unstructured":"Chen TC, Chang HY, Lin PF, Chern JH, Hsu JT, Chang CY, Shih SR: Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob Agents Chemother. 2009, 53: 2740-2747. 10.1128\/AAC.00101-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"554_CR131","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.antiviral.2011.03.187","volume":"90","author":"HJ Thibaut","year":"2011","unstructured":"Thibaut HJ, Leyssen P, Puerstinger G, Muigg A, Neyts J, De Palma AM: Towards the design of combination therapy for the treatment of enterovirus infections. Antiviral Res. 2011, 90: 213-217. 10.1016\/j.antiviral.2011.03.187.","journal-title":"Antiviral Res"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1423-0127-21-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T12:45:00Z","timestamp":1688993100000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/1423-0127-21-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/1423-0127-21-14","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,12]]},"assertion":[{"value":"29 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"14"}}